Skip to main content

Research halted at Seattle hospital

Officials have halted enrollment in more than 600 human research studies taking place in Seattle this week after a federal audit found shoddy paperwork in some consent forms. The Department of Veterans Affair's linkurl:Office of Research Oversight;https://www1.va.gov/oro/ determined in a November audit that the linkurl:VA Puget Sound Health Care System;https://www1.va.gov/pugetsound/ should be more careful in documenting that human subjects are competent enough to make reasoned informed consent.

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Officials have halted enrollment in more than 600 human research studies taking place in Seattle this week after a federal audit found shoddy paperwork in some consent forms. The Department of Veterans Affair's linkurl:Office of Research Oversight;https://www1.va.gov/oro/ determined in a November audit that the linkurl:VA Puget Sound Health Care System;https://www1.va.gov/pugetsound/ should be more careful in documenting that human subjects are competent enough to make reasoned informed consent. Local oversight committees were also censured for not formally judging risk levels on a study by study basis.
"This is a procedural issue," Norm Arkan, a University of Washington spokesperson, told __The Scientist__. "There were no issues here of any subject being in jeopardy with regard to safety issues." "There were administrative oversight issues, and we've begun the process of making changes," added Jeri Rowe, the VA Puget Sound Health Systems' director of public affairs. Researchers can continue collecting data from patients already enrolled in ongoing studies but cannot add new subjects or publish any results until the hospital cleans up its documentation methods, according to the__ linkurl:Seattle Post-Intelligencer.;https://seattlepi.nwsource.com/local/6420ap_wa_va_research.html __The decision applies to about 600 studies being conducted at the hospital and at the University of Washington, and 15 studies at the Fred Hutchinson Cancer Research Center that were actively recruiting bone-marrow transplant and oncology patients at the hospital. Arkan expects that the studies will now be delayed by "several weeks." In the meantime, researchers may have to turn to data analysis and other minor research-related tasks until the wrinkles are ironed out. "The biggest impediment," he said, will be that "our researchers have a lot of paperwork to fill out," but the research will resume eventually.
**__Related stories:__***linkurl:Research halted at UConn neuro lab;https://www.the-scientist.com/news/display/49079/
[6th February 2007]*linkurl:Focus on Seattle;https://www.the-scientist.com/article/display/15141/
[6th December 2004]*linkurl:Research and human subjects;https://www.the-scientist.com/article/display/12054/
[2nd October 2000] *linkurl:Research suspended at Los Angeles VA center;https://www.the-scientist.com/article/display/18491/
[12th April 1999]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo